Billy Amzal

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 330 citations

Medicine, Oncology, Pharmacology +15

Population Toxicokinetic Modeling of Cadmium for Health Risk Assessment

Billy Amzal, Bettina Julin, Marie Vahter et al. · Environmental Health Perspectives · 2009 · 224 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +17

2. Human Risk Assessment of Heavy Metals: Principles and Applications

J.L.C.M. Dorne, George E.N. Kass, Luisa Ramos Bordajandi et al. · Metal ions in life sciences · 2010 · 124 citations

Pharmacy, Environmental Sciences, Toxicology +14

Bayesian-Optimal Design via Interacting Particle Systems

Billy Amzal, Frédéric Y. Bois, Éric Parent et al. · Journal of the American Statistical Association · 2006 · 106 citations

Natural Sciences, Decision Sciences, Mathematics +17

Rivastigmine exposure provided by a transdermal patch versus capsules

François Mercier, Gilbert Lefèvre, Hsun‐Lun Aaron Huang et al. · Current Medical Research and Opinion · 2007 · 78 citations

Pharmacy, Pharmacokinetics, Pharmacology +17